PortfoliosLab logoPortfoliosLab logo
SGRY vs. ENSG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SGRY vs. ENSG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Surgery Partners, Inc. (SGRY) and The Ensign Group, Inc. (ENSG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SGRY achieves a -0.32% return, which is significantly lower than ENSG's 2.35% return. Over the past 10 years, SGRY has underperformed ENSG with an annualized return of -0.88%, while ENSG has yielded a comparatively higher 26.48% annualized return.


SGRY

1D
-3.14%
1M
-10.62%
6M
3.63%
YTD
-0.32%
1Y
-27.63%
3Y*
-25.30%
5Y*
-22.35%
10Y*
-0.88%
ALL TIME*
-1.20%

ENSG

1D
-0.37%
1M
5.91%
6M
3.86%
YTD
2.35%
1Y
17.58%
3Y*
23.67%
5Y*
16.18%
10Y*
26.48%
ALL TIME*
23.29%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$88.77M$87.38M$136.91M
$26.29M$23.55M$22.79M

SGRY vs. ENSG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SGRY
Surgery Partners, Inc.
-0.32%-27.02%-33.82%14.82%-47.84%84.11%85.31%59.91%-19.09%-23.66%
ENSG
The Ensign Group, Inc.
2.35%31.33%18.62%18.89%12.98%15.43%61.43%25.53%75.67%0.78%

Correlation

The correlation between SGRY and ENSG is 0.28, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.28

Correlation (3Y)
Balances recent behavior with more history.

0.35

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.43

Correlation (10Y)
Provides a long-term view across more market conditions.

0.38

Correlation (All Time)
Calculated using the full available price history since Oct 1, 2015

0.37

The correlation between SGRY and ENSG shifts across timeframes, from 0.28 (1 year) to 0.43 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

SGRY:

$2.01B

ENSG:

$10.38B

EPS

SGRY:

-$0.60

ENSG:

$6.38

PS Ratio

SGRY:

0.59

ENSG:

1.93

PB Ratio

SGRY:

1.17

ENSG:

4.34

Total Revenue (TTM)

SGRY:

$3.34B

ENSG:

$5.49B

Gross Profit (TTM)

SGRY:

$763.30M

ENSG:

$775.91M

EBITDA (TTM)

SGRY:

$787.20M

ENSG:

$621.28M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SGRY vs. ENSG — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

SGRY
SGRY Risk / Return Rank: 2020
Overall Rank
SGRY Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
SGRY Sortino Ratio Rank: 1919
Sortino Ratio Rank
SGRY Omega Ratio Rank: 1717
Omega Ratio Rank
SGRY Calmar Ratio Rank: 2323
Calmar Ratio Rank
SGRY Martin Ratio Rank: 2626
Martin Ratio Rank

ENSG
ENSG Risk / Return Rank: 6363
Overall Rank
ENSG Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
ENSG Sortino Ratio Rank: 6464
Sortino Ratio Rank
ENSG Omega Ratio Rank: 6363
Omega Ratio Rank
ENSG Calmar Ratio Rank: 5959
Calmar Ratio Rank
ENSG Martin Ratio Rank: 6262
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

SGRY vs. ENSG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Surgery Partners, Inc. (SGRY) and The Ensign Group, Inc. (ENSG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SGRYENSGDifference
Sharpe ratioReturn per unit of total volatility

-1.32

Sortino ratioReturn per unit of downside risk

-1.85

Omega ratioGain probability vs. loss probability

0.91

1.15

-0.24

Calmar ratioReturn relative to maximum drawdown

-0.58

0.60

-1.18

Martin ratioReturn relative to average drawdown

-0.91

1.57

-2.48

SGRY vs. ENSG - Sharpe Ratio Comparison

The current SGRY Sharpe Ratio is -0.63, which is lower than the ENSG Sharpe Ratio of 0.68. The chart below compares the historical Sharpe Ratios of SGRY and ENSG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SGRY vs. ENSG - Drawdown Comparison

The maximum SGRY drawdown since its inception was -82.86%, which is greater than ENSG's maximum drawdown of -55.57%. Use the drawdown chart below to compare losses from any high point for SGRY and ENSG.


Loading charts...

Drawdown Indicators


SGRYENSGDifference

Max Drawdown

Largest peak-to-trough decline

-82.86%

-55.57%

-27.29%

Max Drawdown (1Y)

Largest decline over 1 year

-51.80%

-31.81%

-19.99%

Max Drawdown (3Y)

Largest decline over 3 years

-69.25%

-31.81%

-37.44%

Max Drawdown (5Y)

Largest decline over 5 years

-81.37%

-31.81%

-49.56%

Max Drawdown (10Y)

Largest decline over 10 years

-82.86%

-55.57%

-27.29%

Current Drawdown

Current decline from peak

-77.03%

-17.39%

-59.64%

Average Drawdown

Average peak-to-trough decline

-42.05%

-12.33%

-29.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

32.83%

12.08%

+20.75%

Volatility

SGRY vs. ENSG - Volatility Comparison

Surgery Partners, Inc. (SGRY) has a higher volatility of 16.88% compared to The Ensign Group, Inc. (ENSG) at 7.50%. This indicates that SGRY's price experiences larger fluctuations and is considered to be riskier than ENSG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SGRYENSGDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.88%

7.50%

+9.38%

Volatility (6M)

Calculated over the trailing 6-month period

32.47%

23.72%

+8.75%

Volatility (1Y)

Calculated over the trailing 1-year period

47.34%

27.84%

+19.50%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

54.98%

26.89%

+28.09%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

64.86%

36.15%

+28.71%

Dividends

SGRY vs. ENSG - Dividend Comparison

SGRY has not paid dividends to shareholders, while ENSG's dividend yield for the trailing twelve months is around 0.14%.


PositionTTM20252024202320222021202020192018201720162015
ENSG
The Ensign Group, Inc.
0.14%0.14%0.18%0.21%0.24%0.25%0.28%0.40%0.47%0.78%0.73%0.67%
SGRY
Surgery Partners, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

SGRY vs. ENSG - Financials Comparison

This section allows you to compare key financial metrics between Surgery Partners, Inc. and The Ensign Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

SGRY vs. ENSG - Profitability Comparison

The chart below illustrates the profitability comparison between Surgery Partners, Inc. and The Ensign Group, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

SGRY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Surgery Partners, Inc. reported a gross profit of 160.20M and revenue of 810.90M. Therefore, the gross margin over that period was 19.8%.

ENSG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, The Ensign Group, Inc. reported a gross profit of 239.83M and revenue of 1.44B. Therefore, the gross margin over that period was 16.7%.

SGRY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Surgery Partners, Inc. reported an operating income of 65.80M and revenue of 810.90M, resulting in an operating margin of 8.1%.

ENSG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, The Ensign Group, Inc. reported an operating income of 122.50M and revenue of 1.44B, resulting in an operating margin of 8.5%.

SGRY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Surgery Partners, Inc. reported a net income of -35.90M and revenue of 810.90M, resulting in a net margin of -4.4%.

ENSG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, The Ensign Group, Inc. reported a net income of 99.74M and revenue of 1.44B, resulting in a net margin of 6.9%.


Frequently Asked Questions


SGRY and ENSG have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SGRY has higher volatility (16.88%) compared to ENSG (7.50%). In terms of maximum drawdown, SGRY dropped -82.86% vs ENSG's -55.57%.

ENSG currently has the higher Sharpe Ratio (0.68 vs -0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SGRY and ENSG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer